• 中国科学论文统计源期刊
  • 中国科技核心期刊
  • 美国化学文摘(CA)来源期刊
  • 日本科学技术振兴机构数据库(JST)

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2019, Vol. 21 ›› Issue (4): 355-358.DOI: 10.3969/j.issn.1671-2587.2019.04.006

Previous Articles     Next Articles

Analysis of Pregnant Women with Positive Irregular Antibodies Treated with Intrauterine Blood Transfusion

YE Zhen, WANG Shu-ping, CHEN Hui-fen, et al   

  1. Shanghai First Maternity and Infant Hospital,Tongji University School of Medicine,Shanghai 201204
  • Received:2018-04-27 Online:2019-08-20 Published:2019-08-28

Abstract: Objective To retrospectively analyze the distribution of antibodies and results of treatments in 8 cases of intrauterine transfusions for positive irregular antibodies and to provide a reference for the clinic treatments. Methods Irregular antibodies and their titers were detected in 8 maternal blood samples and fetal hemoglobin contents and hematocrit were measured with Sysmex xs-800i (five categories) . Results Four of 8 cases of Rh blood group antibodies were found, including one case of anti-CcEe, two cases of anti-D, and one case of anti-DC antibodies. There were 4 pregnant women who showed anti-M antibodies. Eight cases received 27 times of intrauterine blood transfusion, resulting in a notable improvement of fetal hemoglobin content or hematokrit. Correspondingly, the maternal irregular antibody titers were decreased in different degree. Six of the 8 fetuses survived. Conclusion Antibody screening and titer monitoring are required in those who have the history of transfusion, pregnancy, and/or habitual abortions. Ultrasound examination and implement of standardized intrauterine transfusion may improve the environment of the fetal growth .

Key words: Fetal anemia, Intrauterine transfusion, Irregular antibody

CLC Number: